Showing results (141-150 of 149) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2026
Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centersPierre-Louis Benveniste, Laurent Létourneau-Guillon, David Araujo, et al.Journal of Neuroimmunology|August 29, 2006
Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans, Maria Ban, David Booth, et al.Brain : a Journal of Neurology|December 21, 2014
Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patientsXavier Ayrignac, Clarisse Carra-Dalliere, Nicolas Menjot de Champfleur, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2021
Determinants of therapeutic lag in multiple sclerosisIzanne Roos, Emmanuelle Leray, Federico Frascoli, et al.Annals of Neurology|December 23, 2011
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility lociNikolaos A Patsopoulos, , , et al.Neurology|August 17, 2022
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple SclerosisIzanne Roos, Charles Malpas, Emmanuelle Leray, et al.CNS Drugs|September 18, 2021
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International CohortsSifat Sharmin, Mathilde Lefort, Johanna Balslev Andersen, et al.Multiple Sclerosis and Related Disorders|June 11, 2021
The effectiveness of natalizumab vs fingolimod-A comparison of international registry studiesJohanna B Andersen, Sifat Sharmin, Mathilde Lefort, et al.JAMA Neurology|June 27, 2020
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple SclerosisCéline Louapre, Nicolas Collongues, Bruno Stankoff, et al.Pageof 15